Clinical Trials Browser

Refractory Solid Tumors × Other solid neoplasm × 90 days × Clear all

NCT06006273 2026-05-20

A Phase Ib Trial of Eribulin in Combination With Irinotecan and Temozolamide in Children With Relapsed or Refractory Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Refractory Solid Tumors